DiaSorin S.p.A. (0GZX.L)

137,87 +3,48 (+2,59%) In data: 05:10PM BST. Mercato aperto.

DiaSorin S.p.A.

Via Crescentino
Saluggia, VC 13040
Italy
39 01 614871
https://diasoringroup.com/en

Settore/i: 
Settore: 
Impiegati a tempo pieno: 3.184

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Carlo Rosa	CEO, GM & Executive Director	1,75M	N/D	1966
Dr. Chen Menachem Even	Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director	857,25k	N/D	1963
Mr. Piergiorgio Pedron	Senior Corporate VP, CFO & Corporate Accounting Documents Officer	N/D	N/D	1971
Mr. Fabrizio Piercarlo Bonelli	Corporate VP & Chief Technology Officer	N/D	N/D	N/D
Dr. Riccardo Fava	Corporate Vice President of Communication & Investor Relations	N/D	N/D	N/D
Mr. Ulisse Spada	Corporate VP, Head of the Legal Department, Secretary & General Counsel	N/D	N/D	N/D
Mr. Stefano Ronchi	Senior Corporate Vice President of Human Resources	N/D	N/D	1960
Mr. Angelo Rago	President of Luminex Corporation	N/D	N/D	1963

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Governance aziendale

L'ISS Governance QualityScore di DiaSorin S.p.A. al 1 aprile 2024 è 10. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 8; diritti degli azionisti: 9; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.